Dr. John Sweetenham is the executive medical director at Huntsman Cancer Institute and professor in the Department of Medicine, Division of Hematologic Oncology at the University of Utah. He is the author of more than 150 peer-reviewed articles and has served on the editorial board of several medical journals including Hematological Oncology. In addition, Dr. Sweetenham was named in US News & World Report's Top Doctors (2011-2012) and Best Doctors in America from 2003-2012. In 2008, he was named a fellow of the American Association for the Advancement of Science. Dr. Sweetenham completed his fellowships at the Royal College of physicians, Harvard Medical School Tumor Immunology and CRC Wessex Medical Oncology Unity Oncology. He completed his research fellowship at the University of Southhampton Oncology.